Industry Analysis & Industry Trends
The Global Biotechnology industry comprises a diverse range of firms engaged in the development of pharmaceuticals, pest-resistant crops and biofuels, among other products. Revenue for the industry has grown over the past five years and global investment in biotechnology has increased consistently, with much of the added R&D spending funneled into medical applications aimed at providing care for the aging global population. The industry is expected to continue prospering over the next five years, with the Asia-Pacific region making significant investments to gain a foothold in the market. Larger players will increasingly pursue low-risk growth strategies, such as partnering with academic institutions and acquiring smaller firms with products already in the late stages of development... read more
The Global Biotechnology industry uses high levels of capital, but also invests significantly into labor due to the knowledge-intensive nature of the industry. For every dollar spent on labor, $0.33 is spent on capital, making the company slightly more capital intensive.
Generally, for companies with fewer than 50 employees, scientists constitute a slightly larger share of the technical workforce. This is consistent with the more research-focused nature of smaller companies. Larger operators tend to have more engineers largely due to their heavier focus on manufacturing and revenue-earning positions, such as sales. General operations, marketing, and financial managers make up almost half of the workforce... read more